Healthcare >> Sector Roundtables >> April 19, 2010
Thomas P. Kouchoukos returned to Stifel Nicolaus in August 2008 as a Medical Technology Analyst, focusing primarily on the women's health, urology, peripheral vascular, neurovascular and biomaterials market sectors. Prior to joining Stifel Nicolaus, Mr. Kouchoukos was a Vice President and Senior Analyst covering the medical technology sector at Northland Securities, Inc. From 2005 to 2007, he was a Senior Medical Technology Analyst with A.G. Edwards & Sons, and from 2003 to 2005 he served as Vice President and Senior Equity Analyst for Stifel, Nicolaus & Company, following companies in the medical technology sector. Mr. Kouchoukos is a CFA charterholder and member of the CFA Institute and the St. Louis Society of Financial Analysts. He received his Bachelor of Science from Vanderbilt University and his MBA from the Olin School of Business at Washington University in St. Louis.Greg Simpson joined Stifel Nicolaus in July 2003 to cover the medical technology sector. Prior to joining the firm, he spent 15 years at A. G. Edwards as a Vice President and Senior Medical Device Analyst. Mr. Simpson graduated from St. Louis University with degrees in both accounting and finance, and he has an MBA from the University of Missouri. He is a member of the St. Louis Society of Financial Analysts and is a CFA charterholder. Mr. Simpson was ranked first among earnings estimators and second among stock pickers in the health care equipment and supplies industry by the Forbes/StarMine survey in 2007. Profile
TWST: What is your assessment of the medical devices sector, given the recent passage of the health care bill?
Mr. Simpson: It has obviously been an interesting year or so. Reform has clearly been an
